{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:28Z","timestamp":1791919588778,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003220"],"award-info":[{"award-number":["82003220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03112-8","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:14:36Z","timestamp":1738926876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Synergistic strategies for glioblastoma treatment: CRISPR-based multigene editing combined with immune checkpoint blockade"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaolin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maorong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengcong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"5","key":"3112_CR1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1158\/1078-0432.CCR-17-2032","volume":"24","author":"YT Su","year":"2018","unstructured":"Su YT, Chen R, Wang H, Song H, Zhang Q, Chen LY, Lappin H, Vasconcelos G, Lita A, Maric D, Li A, Celiku O, Zhang W, Meetze K, Estok T, Larion M, Abu-Asab M, Zhuang Z, Yang C, Gilbert MR, Wu J. Novel targeting of transcription and metabolism in glioblastoma. Clin Cancer Res. 2018;24(5):1124\u201337.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3112_CR2","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/neuonc\/not125","volume":"15","author":"RC Laxton","year":"2013","unstructured":"Laxton RC, Popov S, Doey L, Jury A, Bhangoo R, Gullan R, Chandler C, Brazil L, Sadler G, Beaney R, Sibtain N, King A, Bodi I, Jones C, Ashkan K, Al-Sarraj S. Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma. Neuro Oncol. 2013;15(12):1635\u201343.","journal-title":"Neuro Oncol"},{"issue":"23","key":"3112_CR3","doi-asserted-by":"publisher","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","volume":"17","author":"Z Cao","year":"2023","unstructured":"Cao Z, Liu X, Zhang W, Zhang K, Pan L, Zhu M, Qin H, Zou C, Wang W, Zhang C, He Y, Lin W, Zhang Y, Han D, Li M, Gu J. Biomimetic macrophage membrane-camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma. ACS Nano. 2023;17(23):23746\u201360.","journal-title":"ACS Nano"},{"issue":"16","key":"3112_CR4","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","volume":"22","author":"T Yin","year":"2022","unstructured":"Yin T, Fan Q, Hu F, Ma X, Yin Y, Wang B, Kuang L, Hu X, Xu B, Wang Y. Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity. Nano Lett. 2022;22(16):6606\u201314.","journal-title":"Nano Lett"},{"issue":"1","key":"3112_CR5","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1038\/s41467-024-50515-6","volume":"15","author":"B Kantor","year":"2024","unstructured":"Kantor B, O\u2019Donovan B, Rittiner J, Hodgson D, Lindner N, Guerrero S, Dong W, Zhang A, Chiba-Falek O. The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders. Nat Commun. 2024;15(1):7259.","journal-title":"Nat Commun"},{"issue":"20","key":"3112_CR6","doi-asserted-by":"publisher","first-page":"20218","DOI":"10.1021\/acsnano.3c05991","volume":"17","author":"K Li","year":"2023","unstructured":"Li K, Xu K, Liu S, He Y, Tan M, Mao Y, Yang Y, Wu J, Feng Q, Luo Z, Cai K. All-in-one engineering multifunctional nanoplatforms for sensitizing tumor low-temperature photothermal therapy in vivo. ACS Nano. 2023;17(20):20218\u201336.","journal-title":"ACS Nano"},{"issue":"27","key":"3112_CR7","doi-asserted-by":"publisher","first-page":"17837","DOI":"10.1021\/acsnano.4c03879","volume":"18","author":"LH Xiong","year":"2024","unstructured":"Xiong LH, Yang L, Geng J, Tang BZ, He X. All-in-one alkaline phosphatase-response aggregation-induced emission probe for cancer discriminative imaging and combinational chemodynamic-photodynamic therapy. ACS Nano. 2024;18(27):17837\u201351.","journal-title":"ACS Nano"},{"issue":"7","key":"3112_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104029","volume":"29","author":"Y Li","year":"2024","unstructured":"Li Y, Pan X, Hai P, Zheng Y, Shan Y, Zhang J. All-in-one nanotheranostic platform based on tumor microenvironment: new strategies in multimodal imaging and therapeutic protocol. Drug Discov Today. 2024;29(7): 104029.","journal-title":"Drug Discov Today"},{"key":"3112_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jconrel.2022.10.019","volume":"352","author":"D Meng","year":"2022","unstructured":"Meng D, Yang S, Yang Y, Zhang L, Cui L. Synergistic chemotherapy and phototherapy based on red blood cell biomimetic nanomaterials. J Controlled Release. 2022;352:146\u201362.","journal-title":"J Controlled Release"},{"issue":"1","key":"3112_CR10","doi-asserted-by":"publisher","first-page":"7164","DOI":"10.1038\/s41467-022-34883-5","volume":"13","author":"Z Qiao","year":"2022","unstructured":"Qiao Z, Zhang K, Liu J, Cheng D, Yu B, Zhao N, Xu FJ. Biomimetic electrodynamic nanoparticles comprising ginger-derived extracellular vesicles for synergistic anti-infective therapy. Nat Commun. 2022;13(1):7164.","journal-title":"Nat Commun"},{"key":"3112_CR11","doi-asserted-by":"crossref","unstructured":"Pranav, Laskar P, Jaggi M, Chauhan SC, Yallapu MM. Biomolecule-functionalized nanoformulations for prostate cancer theranostics. J Adv Res. 2023; 51: 197\u2013217.","DOI":"10.1016\/j.jare.2022.11.001"},{"issue":"5","key":"3112_CR12","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3390\/nano12050809","volume":"12","author":"W Li","year":"2022","unstructured":"Li W, Zhu L, Li K, Ye S, Wang H, Wang Y, Xue J, Wang C, Li S, Liang N, Yang Y. Machine learning-assisted dual-marker detection in serum small extracellular vesicles for the diagnosis and prognosis prediction of non-small cell lung cancer. Nanomaterials. 2022;12(5):809. https:\/\/doi.org\/10.3390\/nano12050809.","journal-title":"Nanomaterials"},{"issue":"1","key":"3112_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-021-00631-2","volume":"6","author":"L Chen","year":"2021","unstructured":"Chen L, Hong W, Ren W, Xu T, Qian Z, He Z. Recent progress in targeted delivery vectors based on biomimetic nanoparticles. Signal Transduct Target Ther. 2021;6(1):225.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"3112_CR14","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1073\/pnas.1420294112","volume":"112","author":"K Xie","year":"2015","unstructured":"Xie K, Minkenberg B, Yang Y. Boosting CRISPR\/Cas9 multiplex editing capability with the endogenous tRNA-processing system. Proc Natl Acad Sci USA. 2015;112(11):3570\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"3112_CR15","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1007\/s12035-022-03150-5","volume":"60","author":"SS Alkanli","year":"2023","unstructured":"Alkanli SS, Alkanli N, Ay A, Albeniz I. CRISPR\/Cas9 mediated therapeutic approach in Huntington\u2019s disease. Mol Neurobiol. 2023;60(3):1486\u201398.","journal-title":"Mol Neurobiol"},{"issue":"11","key":"3112_CR16","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281\u2013308.","journal-title":"Nat Protoc"},{"issue":"1","key":"3112_CR17","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1038\/s41467-022-31926-9","volume":"13","author":"M Reda","year":"2022","unstructured":"Reda M, Ngamcherdtrakul W, Nelson MA, Siriwon N, Wang R, Zaidan HY, Bejan DS, Reda S, Hoang NH, Crumrine NA, Rehwaldt JPC, Bindal A, Mills GB, Gray JW, Yantasee W. Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment. Nat Commun. 2022;13(1):4261.","journal-title":"Nat Commun"},{"issue":"1","key":"3112_CR18","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.1038\/s41467-024-53084-w","volume":"15","author":"Z Huang","year":"2024","unstructured":"Huang Z, Huang S, Song S, Ding Y, Zhou H, Zhang S, Weng L, Zhang Y, Hu Y, Yuan A, Dai Y, Luo Z, Wang L. Two-dimensional coordination risedronate-manganese nanobelts as adjuvant for cancer radiotherapy and immunotherapy. Nat Commun. 2024;15(1):8692.","journal-title":"Nat Commun"},{"issue":"3","key":"3112_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1158\/0008-5472.CAN-16-2482","volume":"77","author":"S Sreedharan","year":"2017","unstructured":"Sreedharan S, Maturi NP, Xie Y, Sundstr\u00f6m A, Jarvius M, Libard S, Alafuzoff I, Weishaupt H, Frykn\u00e4s M, Larsson R, Swartling FJ, Uhrbom L. Mouse models of pediatric supratentorial high-grade glioma reveal how cell-of-origin influences tumor development and phenotype. Can Res. 2017;77(3):802\u201312.","journal-title":"Can Res"},{"issue":"6","key":"3112_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1200\/JCO.21.01881","volume":"40","author":"J Zugazagoitia","year":"2022","unstructured":"Zugazagoitia J, Paz-Ares L. Extensive-stage small-cell lung cancer: first-line and second-line treatment options. J Clin Oncol. 2022;40(6):671\u201380.","journal-title":"J Clin Oncol"},{"key":"3112_CR21","doi-asserted-by":"publisher","first-page":"1067036","DOI":"10.3389\/fimmu.2022.1067036","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Shen L, Wan J, Zhang H, Wu R, Wang J, Wang Y, Xu Y, Cai S, Zhang Z, Xia F. Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: a new era for anal preservation. Front Immunol. 2022;13:1067036.","journal-title":"Front Immunol"},{"issue":"5","key":"3112_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1470-2045(21)00076-0","volume":"22","author":"C Petit","year":"2021","unstructured":"Petit C, Lacas B, Pignon JP, Le QT, Gr\u00e9goire V, Grau C, Hackshaw A, Zackrisson B, Parmar MKB, Lee JW, Ghi MG, Sanguineti G, Temam S, Cheugoua-Zanetsie M, O\u2019Sullivan B, Posner MR, Vokes EE, Cruz Hernandez JJ, Szutkowski Z, Lartigau E, Budach V, Suwi\u0144ski R, Poulsen M, Kumar S, Ghosh Laskar S, Mazeron JJ, Jeremic B, Simes J, Zhong LP, Overgaard J, Fortpied C, Torres-Saavedra P, Bourhis J, Aup\u00e9rin A, Blanchard P. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. Lancet Oncol. 2021;22(5):727\u201336.","journal-title":"Lancet Oncol"},{"issue":"2","key":"3112_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","volume":"9","author":"R Ma","year":"2023","unstructured":"Ma R, Li Z, Chiocca EA, Caligiuri MA, Yu J. The emerging field of oncolytic virus-based cancer immunotherapy. Trends in cancer. 2023;9(2):122\u201339.","journal-title":"Trends in cancer"},{"issue":"3","key":"3112_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.cell.2022.01.008","volume":"185","author":"G Morad","year":"2022","unstructured":"Morad G, Helmink BA, Sharma P, Wargo JA. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell. 2022;185(3):576.","journal-title":"Cell"},{"key":"3112_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jconrel.2024.02.025","volume":"368","author":"W Cao","year":"2024","unstructured":"Cao W, Zhang X, Li R, Li Z, Lu A, Yu F, Sun L, Wang J, Wang Z, He H. Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment. J Controlled Release. 2024;368:52\u201365.","journal-title":"J Controlled Release"},{"key":"3112_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3762\/bjnano.11.25","volume":"11","author":"V Francia","year":"2020","unstructured":"Francia V, Montizaan D, Salvati A. Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine. Beilstein J Nanotechnol. 2020;11:338\u201353.","journal-title":"Beilstein J Nanotechnol"},{"issue":"4\u20135","key":"3112_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.addr.2007.10.005","volume":"60","author":"A Ziegler","year":"2008","unstructured":"Ziegler A. Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans. Adv Drug Deliv Rev. 2008;60(4\u20135):580\u201397.","journal-title":"Adv Drug Deliv Rev"},{"key":"3112_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113961","volume":"178","author":"D Gupta","year":"2021","unstructured":"Gupta D, Zickler AM, El Andaloussi S. Dosing extracellular vesicles. Adv Drug Deliv Rev. 2021;178: 113961.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"3112_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s42003-021-02004-5","volume":"4","author":"SC Jang","year":"2021","unstructured":"Jang SC, Economides KD, Moniz RJ, Sia CL, Lewis N, McCoy C, Zi T, Zhang K, Harrison RA, Lim J, Dey J, Grenley M, Kirwin K, Ross NL, Bourdeau R, Villiger-Oberbek A, Estes S, Xu K, Sanchez-Salazar J, Dooley K, Dahlberg WK, Williams DE, Sathyanarayanan S. ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance. Commun Biol. 2021;4(1):497.","journal-title":"Commun Biol"},{"issue":"5","key":"3112_CR30","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.ymthe.2023.01.021","volume":"31","author":"R Cecchin","year":"2023","unstructured":"Cecchin R, Troyer Z, Witwer K, Morris KV. Extracellular vesicles: the next generation in gene therapy delivery. Mol Therapy. 2023;31(5):1225\u201330.","journal-title":"Mol Therapy"},{"key":"3112_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","volume":"447","author":"M Chen","year":"2019","unstructured":"Chen M, Mao A, Xu M, Weng Q, Mao J, Ji J. CRISPR-Cas9 for cancer therapy: opportunities and challenges. Cancer Lett. 2019;447:48\u201355.","journal-title":"Cancer Lett"},{"issue":"4","key":"3112_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102318","volume":"35","author":"IH Nielsen","year":"2024","unstructured":"Nielsen IH, Rovsing AB, Janns JH, Thomsen EA, Ruzo A, B\u00f8ggild A, Nedergaard F, M\u00f8ller CT, Boesen T, Degn SE, Shah JV, Mikkelsen JG. Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles. Mol Therapy Nucleic Acids. 2024;35(4): 102318.","journal-title":"Mol Therapy Nucleic Acids"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03112-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03112-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03112-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:14:43Z","timestamp":1738926883000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03112-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3112"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03112-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the Institutional Animal Care and Use Committee at the Air Force Medical University (IACUC-20220907).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}